Intracellular calcium homeostasis of motoneurons in animal models of amyotrophic lateral sclerosis by Adalbert, János Róbert
INTRACELLULAR CALCIUM HOMEOSTASIS OF 
MOTONEURONS IN ANIMAL MODELS OF AMYOTROPHIC 
LATERAL SCLEROSIS 
Ph. D, Thesis 
RÓBERT J. ADALBERT 
Institute of Biophysics, Biological Research Center 
2002 

List of publications related to the Ph.D. thesis 
Manuscripts in peer reviewed journals 
L Siklós L, Engelhardt JI, Adalbert R, Appel SH: 
Calcium-containing endosomes at oculomotor terminals in animal 
models of ALS. 
NeuroReport, 10:2539-2545(1999) 
II. Siklós L, Engelhardt JI, Reaume AG, Scott RW, Adalbert R, Obál I, 
Appel SH: 
Altered Ca-homeostasis in spinal motoneuorons but 
not in oculomotor neurons of SOD-1 knock-out mice. 
Acta Neuropathology, 99:517-524(2000) 
III. Adalbert R, Engelhardt JI, Siklós L: 
DL-homocysteic acid application disrupts calcium homeostasis 
and induces degeneration of spinal motoneurons in vivo 
Acta Neuropathologica, in press. 
Presentations at international and Hungarian scientific conferences 
Siklós L, Engelhardt JI, Adalbert R, Appel SH: 
Intracellular calcium distribution of motoneurons with missing- or genetically 
altered superoxide dismutase. 
Brain Pathol., 10:726-727(2000) 
(XIV. International Congress of Neuropatholgy, Birmingham, 
September 3-6,2000.) 
Adalbert R, Engelhardt JI, Siklós L: 
Ultrastructure and calcium distribution of spinal motoneurons 
of rats exposed to excitotoxins in vivo. 
IBRO-MITT Meeting, January 19-22,2000, Budapest. 
Adalbert R, Siklós L, Engelhardt JI: 
Ultrastructural alterations and changes in the homeostasis of calcium in 
spinal motor neurons in acute excitotoxic injury. 
33th Annual Meeting of the Hungarian Society of Neurologists and 
Psychiatrists, November 16-18,2000, Budapest. 
Adalbert R, Engelhardt JI, Siklós L: 
Structural changes and specificities of the calcium homeostasis of 
motoneurons during excitotoxic lesions. 
Annual Scientific Meeting of the Biological Research Center, November 29-
December 1,2000, Szeged. 
Siklós L, Adalbert R, Obál I, Engelhardt JI: 
Modifications of the neuronal calcium homeostasis in relation to the 
Degenerative alterations of motoneurons. 
8th Meeting of the Hungarian Neuroscience Society, 
January 24-27,2001, Szeged. 
Contents 
1. Introduction I. 
1.1 Historical overview 1. 
1.2 Terminology and definition 1. 
1.3 Epidemiology 2. 
1.4 Clinical and pathological features of ALS 3. 
Diagnosis of ALS 3. 
Pathology of ALS 3. 
1.5 Basic theories of the pathomechanism of ALS 5. 
Autoimmunity 6. 
Excitotoxicity 6. 
Oxidative stress 7. 
Neurofilament inclusions and altered axonal transport 9. 
1.6 Hypothesis and aims of the study 10. 
Working hypothesis 10. 
Prior studies supporting our hypothesis 2 10. 
Aims of the study 12. 
2. Materials and methods 14. 
2.1 Animal strains 14. 
Animals for the s ALS models 14. 
Animals for the fALS models 15. 
2.2 Specimen preparation for electron microscopic histochemistry 15. 
2.3 Transmission electron microscopic examinations 16. 
2.4 Quantitative characterization of calcium distribution 17. 
2.5 Analytical microscopy 17. 
3. Results 19. 
3.1 Ultrastructure and calcium distribution of spinal 
motoneurons in excitotoxicity 19. 
3.2 Similar alterations of the motoneuronal calcium induced 
in the autoimmune- and oxidative stress models of ALS 22. 
3.3 Ultrastructure and calcium distribution in spinal-
and oculomotor neurons of SOD 1 knock-out mice 25. 
4. Discussion 29. 
4.1 Excitotoxic lesion of motoneurons in vivo 29. 
4.2 Correlation of disturbed calcium homeostasis of vulnerable 
and resistant motor axon terminals in models of 
familial- and sporadic ALS 32. 
4.3 Cooperation of cytosolic free-radical- and calcium homeostasis 
in SOD1 knock-out animals 34. 
4.4 A synthetic model of the calcium-mediated degeneration of 
motoneurons in amyotrophic lateral sclerosis 37. 
5. Acknowledgement 39. 
6. References 40. 
7. Appendix 53. 
1 
1. Introduction 
1.1 Historical overview 
Progressive muscular wasting was a clinical syndrome well known to physicians 
already in the early 19th century. The term progressive muscular atrophy (PMA) was 
introduced by Aran, who believed that this syndrome was a muscular disorder [Aran, 
1850]. In the same time, however, Cruveilhier, who noted the degeneration of the 
anterior spinal roots, regarded PMA as a myelopathic disorder [Cruveilhier, 1853]. 
Progressive bulbar palsy (PBP) was first described by Duchenne [Duchenne, 1860] 
who, similar to Aran, also favoured a muscular cause of the disease. It was Charcot 
and Joffroy who studied just the same bulbar motor nuclei, and recognizing loss of 
motoneurons concluded that the disease was of neurogenic origin. The diagnostic 
criteria they used remained valid to the present days [Charcot and Joffroy, 1869]. Five 
years after the original description of two cases, the term for amyotrophic lateral 
sclerosis, in brief ALS, was introduced by Charcot when he extended his first 
observation by systematic characterization of 20 other patients [Charcot, 1874], 
1.2 Terminology and definition 
The term motoneuron disease (MND) was introduced by Brain, in recognition of 
the relation between the syndromes of ALS, PMA and PBP [Brain, 1962]. This term 
has become commonly used in the specialized English literature, although Charcot's 
designation of ALS was prefered in the continental Europe. Nowadays, the general 
term MND is used to describe a family of degenerative lower motoneuron (LMN) and 
the upper motoneuron (UMN) disorders, as shown in Table 1 [Swash, 2000]. 
Because the non-ALS patients account for not more than 10-15 % of cases of 
MND, their impact on the statistics data of differential diagnosis, mortality, frequency 
etc. is practically negligible [Eisen and Krieger, 1998]. In the USA, as a memory for 
the famous baseball player, Lou Gehrig's disease is more often used as the name for 
ALS. 
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According to the present definition, 
ALS is a relentlessly progressive, 
invariably fatal disease of the central 
nervous system. It is characterized by 
the degeneration of the upper 
motoneurons (UMNs) and lower 
motoneurons (LMNs) in the brain and 
spinal cord, associated with the 
neurogenic atrophy of muscles. At the 
begining, the disorder is often 
asymmetric and it may be quite localized. The varying extent and localization of the 
involvement of the motor system results in differing clinical features, but ultimately, 
as the disorder progresses, the clinical expression of the disease is rather uniform, 
with extreme muscular wasting and spasticity. Usually, death results from respiratory 
failure in 2 to 4 years after diagnosis. 
1.3 Epidemiology 
% 
ALS, which afflicts primarily middle-aged adults, occurs in about 1.6-7.0 people 
per 100,000 population (mean value 4.1 / 100,000) [Kondo, 1996]. Previous data have 
shown an unusually high incidence foci of motor neuron disease in the Kii Peninsula, 
Guam- and Mariana Island and West New Guinea. Since 1970, however, a dramatic 
fall in the incidence of ALS has been observed in these area, resulting in a rather 
homogeneous worldwide distribution [Yanagihara et al., 1996]. More recent data 
shows a prevalence of about 0.8-2.6 people / 100,000 population per year [Belsh, 
1996]. Statistical analysis revealed an increasing occurrence of the disease in the last 
few years, which can be attributed to an increased life expectancy rather than a true 
increase in the occurrence [Kondo, 1996]. There is a sexual prevalence, males are 1.5-
2 times more affected than females which makes ALS unique among 
neurodegenerative diseases. Therefore, besides age, sex is the second most important 
risk factor in ALS. The importance of physical trauma as a risk factor, although 
repeatedly emphasized in the litearature, is still controversial [Belsh, 1996]. ALS 
exists also in familial form, which constitutes 5-10% of the total ALS cases. 
Table 1. Idiopathic motoneuron diseases 
(According to Swash [2000]) 
Amyotrophic lateral sclerosis (ALS) 
Progressive bulbar palsy (PBP) 
Progressive muscular atrophy (PMA) 
Primary lateral sclerosis (PLS) 
Familial amyotrophic lateral sclerosis 
Juvenile amyotrophic lateral sclerosis 
Madras motoneuron disease 
1.4 Clinical and pathological features of ALS 
Diagnosis of ALS 
Currently, there is no specific marker or unique test for the diagnosis of ALS. 
Therefore, the diagnosis of ALS is based on an array of clinical, electrophysiological 
and neuroradiological tests. The goal is to identify the local or general involvement of 
the motor system and to exclude other conditions, which may mimic ALS. Clinical 
and pathological criteria for diagnosis have been defined at conferences held in El 
Escorial in 1994 and revised at Airlie House, Virginia [Brooks et al., 2000]. The 
Airlie House criteria currently used for the diagnosis of ALS are shown in Table 2. 
Table 2. Airlie House Criteria for the diagnosis of ALS 
To be proved: To be excluded: 
Degeneration of lower motoneurons 
(clinical, electrophysiological, or 
neuropathological examinations) 
Other disease processes that might 
explain the signs of LMN or UMN 
degeneration (electrophysiological, or 
pathological examinations) 
Degeneration of upper motoneurons 
(clinical examination) Other disease processes that might 
explain the observed clinical and 
electrophysiological signs (neuroimaging 
examinations) 
Progression of the motor syndrome 
within a region or to other regions, as 
determined by case history or repeated 
examinations 
Pathology of ALS 
The major pathological features of ALS are the degeneration of lower 
motoneurons (anterior hom cells), myelin pallor in the corticospinal projection 
pathway and the loss of large calibre axons from peripheral nerves [King and 
Mitsumoto, 1996]. The onset of symptoms seen in ALS patients is assumed to occur 
when approximately a 50-80% loss of motoneurons has been achieved [Brooks et al., 
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2000]. These, almost dogmatic statements, however, are not completely supported by 
the most recent quantitative morphometric investigations [Ince, 2000]. This will be 
exemplified by the results of attempts to assay the number of upper and lower 
motoneurons. 
Upper motoneurons: The most severely affected region is cortical layer 5, where 
an obvious absence of the giant pyramidal (Betz) cells can be noted, accompanied by 
reactive gliosis (astrocytosis) and diffuse microgliosis. Due to the lack of specific 
markers for Betz cells, these findings were based on conventional Nissl-stained 
material. Thus, shrinkage of giant pyramidal cells to the extent, which makes them 
indistinguishable from neighbouring pyramidal cells, could also explain the virtual 
absence of the Betz cells. Therefore, the previous findings might be at least partially 
confusing [Gredal et al, 2000]. 
Lower motoneurons: Studies based on 3-dimension morphometric probes 
demonstrated that the mode of neuronal degeneration in the case of lower 
motoneurons appears to be predominantely shrinkage, similar to upper motoneurons. 
Further evidence for the occurrence of neuronal shrinkage, prior to neuronal loss, 
comes from studies of peripheral nerves where quantitative analysis has shown a 
systematic reduction of axonal diameters which is more prevalent than an overall 
decrease in absolute numbers of axons [Dyck et al., 1975]. Although, aspects of such 
morphological alterations might help in identifying the actual mechanism of 
motoneuron degeneration, in the case of ALS, the picture is rather complicated. 
Several recent studies revealed that in ALS motoneuron death follows neither 
apoptotic nor necrotic pathways but most probably takes place in a necrosis-apoptosis 
continuum, exhibiting intermediate forms with features of both modes of cell death 
[Ince, 2000]. 
In skeletal muscles the typical changes have features of denervation atrophy with 
clusters of angular atrophic fibres. This clustering, fibre-type grouping is a non-
specific consequence of a series of denervation and compensatory reinervation. The 
reinervation arises from the collateral sprouting of intramuscular axons [Wohlfart, 
1957]. 
At present, besides classical pathological and histochemistry techniques, 
intracellular lesions of motoneurons are increasingly investigated by modem 
molecular techniques, which are based on specific intracellular markers. Such studies 
revealed proximal axonal enlargements in motoneurons [Carpenter, 1968], 
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fragmentation of the Golgi apparatus detected with organelle specific antibodies 
[Gonatas et al, 1992], and a range of intracellular inclusion bodies. The major type of 
inclusion seen in motoneurons are Bunina bodies (small eosinophilic bodies present in 
approximately 70% of autopsy cases of ALS), ubiquitinated inclusions (compared 
with other neurodegenerative diseases, those in ALS do not contain neurofilaments), 
and hyaline inclusions. The hyaline inclusions which are associated with the lesion of 
neurofilaments may occur as globules or in diffuse forms and are weakly 
immunoreactive with ubiquitin. In comparision with other neurodegenerative 
diseases, the above mentioned pathological changes are less characterized, they are 
less specific for ALS, furthemore, little is known about their evolution and their role 
in the disease. 
1.5 Basic theories of the pathomechanism of ALS 
ALS has an unknown etiology and there is a limited understanding of the 
mechanism of motoneuron injury and loss. Therefore, only hypotheses have been put 
forward so far to explain for the selective degeneration of motoneurons in ALS. The 
present hypotheses rely on isolated causative factors or ¿dividual features of the 
pathological mechanism of the disease, since there is no generally valid concept 
available, which explains all the aspects of ALS. The basic mechanisms of the four 
most popular theories, based on phenomena involving autoimmunity, excitotoxicity, 
oxidative stress and cytoskeletal abnormalities are illustrated in Fig. 1, below. 
Autoimmunity Excitotoxicity Oxidative stress Impaired axonal transport 
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Autoimmunity 
Any hypothesis for the patomechanism of ALS must account for the specificity, 
i.e. why only motoneurons are involved in the disease, and for the selectivity, namely 
why some motoneurons are affected while others are not. The fact that there is a 
specific motoneuronal vulnerability favours the idea that autoimmune mechanisms 
may be involved in the pathogenesis of ALS. A support for this hypothesis first came 
from studies which indicated the presence of antibodies (IgG) for L-type voltage 
gated Ca2+ channels in 75% of sporadic ALS patients [Smith el al., 1992]. Other 
studies have shown that ALS IgG binds the ionophore containing the a l subunit of 
the voltage-gated Ca2+ channels [Kimura et al., 1994], ALS IgG can interact and alter 
the function of muscular L type calcium channels [Magnelli et al., 1993], and 
neuronal N-/ P-/ Q-channels, as well [Llinas et al., 1993]. The interaction of ALS IgG 
with these calcium channels enhances inward calcium current because of the 
prolonged channel open time [Mosier et al., 1995] and increases intracellular calcium 
as was demonstrated in a motoneuron cell line. These results are in agreement with in 
vivo studies where IgG reactivity [Engelhardt and Appel, 1990] and limphocytic 
infiltrations in spinal cords of ALS patients were seen [Engelhardt, et al., 1993]. The 
release of inflamatory cytokines may account also for the progression of ALS: first 
the limbs are affected on one side and then the disease progresses to the opposite side 
and finally attacks the muscles of the head. 
Despite such observations, at present we cannot say for certain that ALS is an 
autoimmune disease. The failure of immunosupression in ALS [Brown et al., 1986; 
Drachman et al., 1994], and the lack of success of inducing motoneuron degeneration 
in animals by IgG inoculation, are the main obstacles against proposing an immune-
mediated etiology. 
Excitotoxicitv 
Glutamate is the major excitatory neurotransmitter in the mammalian central 
nervous system, which acts through ionotropic or metabotropic receptors. Excessive 
glutamate accumulation in the synaptic cleft or a functional alteration of the glutamate 
receptors may lead to an overactivation of the synapse, which finally results in an 
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excitotoxic neuronal death [Choi, 1992]. The excitotoxicity hypothesis is supported 
by observations, which suggest that the excitotoxic lesions play an important role in 
motoneuron degeneration. It has been shown that glutamate levels in the plasma of 
ALS patients were two fold higher compared to controls (Plaitakis and Caroscio, 
1987) and high levels of glutamate and aspartate have been detected in cerebrospinal 
fluid from ALS patients (Rothstein et al., 1991). A rapid uptake of the released 
glutamate is accomplished by the EAAT1 and EAAT2 glutamate transporters present 
in astrocytes [Mitsumoto et al., 1997]. Thus, a loss or a decreased activity of these 
glutamate transporters could lead to an increased extracellular concentration of 
glutamate. A support for this idea came from the study of Rothstein and colleagues 
[1995] who found that majority of sporadic ALS patients (about 65%) have a reduced 
level of the EAAT2 astroglial glutamate transporter in the motor cortex and spinal 
cord. 
In other studies it was documented that some ALS patients have alterations of the 
AMPA glutamate receptor structure, which were sufficient to induce excitotoxicity. 
Under normal physiological conditions AMPA receptors are impermeable to calcium. 
However, if one of its subunits is missing (GluR2), the AMPA receptors become 
permeable to calcium ions [Sommer et al,, 1991]. During neurotransmission this 
alteration induces an increased calcium influx into the postsynaptic motoneurons, 
which may trigger motoneuron injury. The low expression of the GluR2 protein 
subunit [Williams et al., 1997], or of the mRNA for the GluR2 [Takuma et al., 1999] 
seen in ALS patients, can indeed induce the above-mentioned pathological processes. 
Like the autoimmunity hypothesis, the excitotoxicity hypothesis does not provide 
an explanation for the familiar form of ALS. Moreover, there is no specificity for the 
reduced expression of the glutamate transporters, since alterations could be also found 
outside of the motor system, and in other neurodegenerative diseases, as well. Finally 
clinical experience suggest that neither Gabapentin (which inhibits the syntesis of 
glutamate) nor Riluzole (which inhibits the glutamate release), could influence the 
outcome of the disease [Rowland, 2000]. 
Oxidative stress 
It is well documented that cellular injury can be induced by overproduction of 
free radicals, which exposes the tissue to oxidative stress [McCord, 1985]. The 
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phenomenon regained the attention of scientists investigating the patomechanism of 
ALS after discovering that missense mutations in the SOD1 (superoxide dismutase 1, 
or Cu-Zn SOD) gene are present in some 1-2% of ALS cases [Rosen et al., 1993]. 
SOD1 catalyses the neutralization of superoxide anions in physiologic and pathologic 
conditions [Halliwell, 1992]. It is not yet known whether a loss of function or a toxic 
gain of function of mutant SOD1, or both, are responsible for motor neuron injury in 
ALS. There is, however, compelling evidence favouring the gain of function 
hypothesis. When testing the disease mechanism, the elimination or elevation of wild-
type SOD1 was found to have no effect on mutant-mediated disease [Bruijn et al., 
1998]. Many of the missense mutations in SOD1 have the potential to alter the active 
site of the SOD1 enzyme. X-ray crystallographic studies have demonstrated that the 
active channel of the mutant SOD1 protein is larger than that of the wild-type enzyme, 
enabling greater accessibility or unshielding of the cooper active site [Deng et al., 
1993]. Such changes could allow mutant SOD1 to react with additional substrates 
such as hydrogen peroxide and peroxynitrite [Beckman et al., 1993; Wiedau-Pazos et 
al., 1996]. These aberrant reactions could lead to an increased cellular production of 
highly reactive and damaging free radical species such as hydroxyl radicals and 
nitronium ions, and nitration of tyrosine residues of susceptible proteins. It is also 
feasible that not the aberrant oxidative activity of SOD1 which is responsible for the 
neurotoxicity, but rather, the increased aggregation of this protein may contribute to 
neuronal degeneration [Cleveland and Liu, 2000]. Such protein aggregates can be 
commonly seen not only in ALS but in other neurodegenerative diseases, as well. 
Many transgenic mouse models expressing human mutant SOD1 have been 
generated, but these mice develop clinical and neuropathological alterations, which 
only partly resemble changes observed in human ALS. These animals die at the age of 
5-10 months, depending on the quality and quantity (copy number) of the transgene 
employed [Gurney et al., 1994], Although transgenic animals are the most commonly 
used models in ALS, there are some problems regarding the extrapolation of the 
results to the human case. Despite the positive benefits of Riluzole and vitamin E in 
transgenic mice [Gurney et al., 1996], for example, these agents proved ineffective in 
clinical trials with ALS patients [Rowland and Shneider, 2001]. Moreover, the 
oxidative stress hypothesis offers explanation only for a minor, not more than 1-2% of 
diagnosed ALS cases. 
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Neurofilament inclusions and altered axonal transport 
The idea that aberrant accumulation of neurofilaments may play a role in ALS 
was first suggested by the discovery that accumulation and abnormal assembly of 
neurofilaments are common pathological hallmarks in the majority of ALS patients 
[Hirano, 1991]. However, it is not yet known whether the abnormal accumulation of 
neurofilaments is a consequence of axonal transport blockade or whether the 
accumulation of these proteins leads to secondary impairment of axonal transport 
[Shaw and Egget, 2000]. 
The most abundant structural proteins in neurons are the intermediate 
neurofilaments (IF) which are assembled from three polypeptide subunits of differing 
molecular weights: NF-light (NF-L), NF-medium (NF-M) and NF-heavy (NF-H). The 
first evidence that neurofilament accumulations can cause motoneuron disease 
emerged from the expression in transgenic mice of three or four times the normal 
level of NF-L [Xu et al., 1993]. Despite the fact that the morphological changes were 
similar to those seen in humans (perikaryonal neurofilament accumulation) these mice 
did not exhibit motoneuron death. Next, to examine whether aberrant neurofilament 
subunits could be a direct cause of motoneuron degeneration, several lines of 
transgenic mice were constructed to express mutations of NF-L. In this experiment 
motoneuron death could finally be induced [Lee et al., 1994]. Based on such results, 
large-scale investigations were initiated, and mutation of the NF-H subunit gene could 
be found in approximately 1% of ALS population [Bruijn et al., 2000]. 
The presence of aberrant neurofilament accumulations in familial ALS suggests 
that neurofilaments may be a target for free radicals and therefore, may act as toxic 
intermediates in the disease. The results of the studies, which tried to clarify this 
assumption are still controversial. In one study, in which mice deleted for the NF-L 
gene were bred with mice that express the mutant SOD1 gene, the absence of 
neurofilaments "delayed disease onset and produced a significant increase in life span 
[Bruijn et al., 2000]. Since in these animals only perikaryonal inclusions could be 
seen, it was concluded that neurofilament accumulation attenuates the damaging 
effect of SOD1 mutant enzyme, likely by means of buffering the calcium load at the 
perikaryon by the accumulated proteins [Julien, 2001]. In another study the 
motoneuron degeneration induced by periferin (IF protein) overexpression was 
dramatically accelerated by the absence of NF-L [Julien, 2001]. 
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In summary, it can be concluded that cytoskeletal abnormalities may be viewed 
as important risk factors in ALS, however, different types of IF inclusions may have 
unique effects on motoneuron function. 
1.6 Hypothesis and aims of the study 
Working hypothesis 
Despite the accumulating data that autoimmunity, excitotoxicity and the aberrant 
accumulation of neurofilaments are involved in sporadic ALS, as well as, mutant 
SOD1 in familial ALS, none of these mechanisms explains sufficiently the observed 
selective vulnerability in motoneuron populations. Although animal models developed 
on the basis of each theory could be effectively used to study some individual 
molecular pathways, the development of the disease was always attributed to a single 
etiological factor. Each model showed numerous pathological characteristics similar 
to those found in the human disease, yet it is not possible, from these studies, to 
conclude that ALS is purely an autoimmune, excitotoxic, free radical-mediated or 
neurofilamentary disease. Instead, based upon our present knowledge, it is more likely 
that ALS is a multifactorial disease, in which the already known, or as yet unknown, 
pathogenic processes contribute cooperatively to the development of the disease 
[Eisen, 1995]. 
Our hypothesis is that in the development of a uniform clinico-pathologic profile 
of ALS the crucial step is the irreversible damage of the calcium homeostasis of 
motoneurons. Changes in the levels of intracellular calcium could link, synchronise 
and amplify the various processes, regardless of whether the initial trigger to the 
lesion of motoneurons was associated with oxidative stress, immune mechanisms, 
excitotoxic activity, or other genetic or environmental factors, yet to be defined. 
Prior studies supporting our hypothesis 
The neurofilament accumulation, which is typical of ALS autopsy samples, is 
also observed in motoneurons from the SOD1 transgenic animals used as model 
systems of the free radical lesion. Through genetic manipulation, neurofilament 
overexpressing and knock-out (-/-) mice have been developed [Collard et al, 1995]. 
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Crosses of SOD1 transgenic mice with NF-L -/- mice results in a significant 
retardation of the experimental disease [Williamson et al, 1998], which indicates that 
neurofilament accumulation plays an active role in neuronal damage caused by free 
radicals. The passive transport of ALS IgG into mice, can induce the phosphorylation 
of neurofilament H [Engelhardt et al, 1995], which further strengthens the postulate 
that these differentiated processes are linked to one another. 
Examination of SOD1 transgenic mice shows that the astrocytes are also 
damaged. In the final stages of the modelled disease, it is possible to detect a 50% 
decrease in the amount of glial glutamate transporter (EAAT2) [Bruijn et al, 1997], 
indicating that the SOD1 mediated free radical damage may result in secondary 
excitotoxic lesions. The relationship of both excitotoxicity and oxidative stress, with 
the calcium regulation, is well known in the literature. The binding of glutamate to 
excitatory amino acid receptors may induce substantial calcium influx [Choi, 1988], 
or, vice versa, an increase in transmitter release may be evoked by an increase in the 
influx of calcium. Furthermore, increase in calcium levels may result in elevated free 
radical production through the interactions of calcium-activated enzymes 
(phospholipase A2, calpain I, II, xanthin-oxidase) [Mitsumoto et al, 1997]. Recent 
studies of intracellular calcium homeostasis and the levels of free radicals suggest 
more complex and synergistic relations [Mattson, 1998]. 
If intracellular calcium levels are, in fact, the key factors in ALS-type 
motoneuron injury, is it probable that the stability of calcium regulation, for example 
through calcium-buffering by calcium-binding proteins, and the vulnerability of the 
motoneurons are interconnected variables. On the basis of immunocytochemical 
studies of ALS autopsy samples it seems that the decrease or absence of calbindin-
D28K and parvalbumin, in populations of motoneurons parallels their vulnerability 
during the course of the disease. In the early stages of the disease, the affected cells 
(spinal motoneurons, XII nucleus) do not contain these proteins, while those cells 
which are only affected later (III, IV, VI nuclei, Onufrowitz nucleus) may be 
immuno-labelled for these proteins [Alexianu et al, 1994, Elliott and Snider, 1995]. 
Experiments carried out on an in vitro motoneuron cell line exhibited compatibible 
results: undifferentiated VSC 4.1 motoneurons remained resistant to the effects of 
IgG, purified from an ALS patient, while they contained calbindin-D28K and 
parvalbumin. Yet, after their differentiation, once they had lost these proteins, the 
same IgG resulted in calcium influx and caused cell death [Ho et al, 1996]. If these 
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cells were transfected with calbindin-D28K cDNA, the level of this calcium-binding 
protein remained high, even in differentiated cells and the cell remained viable when 
treated with ALS IgG [Ho et al, 1996]. The precise physiological functions of 
calbindin-D28K and parvalbumin are not yet known. However, based on these 
observations and other data from the literature, they appear to play a role in the 
stabilisation of calcium homeostasis of the cell, either through the regulation of 
calcium influx, sequestration of intracellular calcium, or calcium efflux [Lledo et al, 
1992], 
Aims of the study 
As we have seen, several attempts have been made on diverse theoretical 
backgrounds for the interpretation of the pathomechanism of ALS. These theories, 
while successfully explain certain cascades of molecular events, cannot account for 
the uniform clinico-pathological picture of the disease, particularly, when the 
apparently distantly related sporadic and familial forms are considered. Our approach 
is based on the assumption that the initial injury may be triggered by a variety of 
causes, then the primary pathology initiates a cooperative process during which the 
sensitivity of neurons to further damaging insults is continuously increasing. In this 
positive-feedback loop, calcium-dependence may be a common factor in all of the 
stages. Our previous experiments have shown that in autoimmune- or purely oxidative 
stress induced lesion, the calcium regulation of motoneurons is disturbed, 
degenerative changes are induced which may lead to the destruction of the cells. In 
our present experiments, we are extending our studies to other ALS models, with the 
final aim to prove that the observed components of the pathomechanism of ALS could 
be linked to each other through their ability to increase the calcium level of 
motoneurons. Furthermore, we attempt to study the function and relationship of some 
cellular mechanisms (calcium buffering, antioxidant defense) supposed to play a 
major role in the pathomechanism of ALS, according to the present theories. Our 
specific aims are: 
• Ultrastructural characterization of motoneuronal calcium distribution in 
excitotoxic-stress induced lesions in vivo. 
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Investigation of the similarities of the disturbed calcium homeostasis of 
motoneurons with different Ca-binding protein content in the autoimmune- and 
oxidative stress model. 
Investigation of the role of SOD1 in the stabilization of calcium homeostasis of 
parvalbumin-containing and parvalbumin-deficient motoneuron populations using 
SOD1 knock-out animals. 
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2. Material and Methods 
2.1 Animal strains 
To study the alterations of calcium distribution of motoneurons in animal models 
of sporadic and familial ALS, experimentally treated or genetically modified animals 
were used, respectively. All animal experiments were performed according to the 
appropriate institutional guidelines and governmental laws for animal protection. 
Animals for the sALS models 
Passive transfer of ALS IgG: To mimic the chronic conditions present in the 
patients Wistar rats were inoculated regularly with intraperitoneal injection of IgG 
from ALS patients. IgG purified from the blood of a patient with demyelinating 
polyneuropathy was used as control. Injections were started on the day of birth of 
animals to reduce the response of their immune system against the foreign IgG. The 
dose of the injected IgG, with the initial amount of 10 mg protein/day, was adjusted 
continuously to the weight of animals. Rats were killed at the age of 30 days. 
Excitatory amino acid application (EAA): Male, 21 days old CFY rats were used 
for the experiments, which were sorted to control- and EAA-treated groups. Rats in 
the EAA-treated group were allowed to survive for 1, 3, 6, and 24 h following 
treatment with D,L-homocysteic acid (DL-HCA), a non-specific agonist of 
AMPA/kainate and NMDA receptors (730 pg DL-HCA injected in 10 pi of 400 mM 
solution, pH 7.4). Rats were first deeply anesthetized with intraperitoneal injection of 
xylazine (12 mg/kg) and ketamine (108 mg/kg), then their spinal cords were exposed, 
by removing the posterior arches of the lumbar vertebrae over 2-3 segments, finally, 
DL-HCA was injected subdurally. Control rats were treated similarly, but injected 
with vehicle only (10 pi distilled water with adjusted pH to 7.4). After the surgery the 
skin over the spine was sutured and the animals were allowed to recover. 
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Animals for the fALS models 
SOD1 mutant transgenic animals: The human SOD1 transgene, containing the 
G93—>A mutation [Rosen et al, 1993], including the promoter and enhancer sequences 
for transcription, were injected into the fertilized eggs of C57BL6 x SJL F1 hybrid 
mice [Gurney et al, 1994]. Founder animals were bred with C56BL6 mice. In their 
progeny (G1H+ line) the transgene was identified by polymerase chain reaction 
amplification of tail DNA. The transgene copy number (n=20) was determined by 
Southern DNA hybridization. A N28+ line was developed as a control strain, in which 
the wild type human SOD 1 gene was expressed with similar copy number. Mice were 
obtained from Jackson Laboratory (Bar Harbor, Maine) for our experiments. 
SOD1 knock out animals: SOD 1 knock out animals were developed on the basis 
of CD-I mouse strain. Using homologous recombination in embryonic stem cells, the 
entire coding sequence of the mouse SOD1 gene has been deleted. These mutant cells 
were used to create mice homozygous for the SOD1 deletion (SOD 1"'') [Reaume et al, 
1996]. Blood samples were used to confirm that the targeted deletion of SOD 1 gene 
resulted in no detectable amount of Cu/Zn SOD protein and only a minor level of 
enzyme activity. CD-I mice were used as controls. Mice were obtained from 
Cephalon, Inc. (West Chester, Pennsylvania). 
2.2 Specimen preparation for eletron microscopic histochemistry 
The aim of our specimen preparation is to preserve both the organization of the 
tissue and the distribution/amount of calcium at the ultrastructural level. This dual 
goal requires a fixative of special composition, which should be ideally applied by 
perfusion through the blood circulation. Thus, all the animals were first deeply 
anaesthetized, then transcardially perfused with the fixative, containing 3% 
glutaraldehyde and 90 mM potassium oxalate (pH 7.4, adjusted with KOH) [Borgers 
et al, 1979, 1981]. In some experiments, prior to the application of the fixative, the 
blood was flushed out with a plain 90 mM potassium oxalate solution (pH 7.4), but 
the two procedure yielded equivalent structural preservation and calcium retention. 
Following perfusion, depending on the actual experimental paradigm, samples were 
dissected out from the (a) hindlimb interosseus muscle, (b) external eye (superior 
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rectus) muscle, (c) lumbar segment of the spinal cord, and (d) a region from the 
brainstem containing the oculomotor nucleus. After dissection, specimens were placed 
in the primary fixative for 24h at 4°C, then rinsed for 15 min in 90 mM potassium 
oxalate, containing 7.5 % sucrose, and postfixed for 2 hours in a solution of 1 % 
osmic acid and 2% potassium pyroantimonate (pH adjusted to 7.4 with acetic acid). 
Following postfixation tissue samples were rinsed in distilled water (pH 10.0 with 
KOH), dehydrated in graded series of ethanol, processed through propylene oxide and 
embedded in Durcupan ACM. Blockes were polymerized for 2 days at 56°C. After 
polymerization 0.5 pm thick sections were cut on a RMC MT-7, or on a Reichert UM 
II ultramicrotome and stained according to Richardson [I960]. Sections were screened 
in a light microscope for the presence of preterminal branches of the motor nerves, or 
large motoneurons in muscle samples or nerve tissue, respectively. For an unbiased 
selection of the fields for microscopic examinations random numbers were generated 
(1 < n < 20) and "n" number of 0.5 pm thick sections were cut and discarded. Then, 
from this new starting point, ultrathin sections were obtained at regular, 20 pm 
intervals [Cruz-Orive, 1988; Gundersen et al, 1987]. Ultrathin sections were mounted 
on formvar-coated single-hole copper grids, stained with uranyl acetate [Hayat, 1970] 
and lead citrate [Reynolds, 1963], then examined in a Philips CM 12 or Zeiss CEM 
902 electron microscope. 
2.3 Transmission electron microscopic examinations 
When only qualitative description of the calcium distribution and the structural 
alteration of the tissue was aimed, sections (containing neuromuscular synapses or 
motoneurons from different brain regions) were studied carefully at a low-to-medium 
instrumental magnification (3,000 - 10,000 x) to determine the general features of the 
objects to be characterized. Conventional bright field imaging with instrumental 
parameters of 80 kV accelerating voltage, and 30 pm objective aperture was used for 
this purpose. Conclusions with regard to the changes compared to appropriate controls 
were regularly established on the basis of inspecting of 30-40 randomly selected 
features. Then, sample photographs were made in suitable primary magnifications, 
regularly at 10,000 - 30,000 x, documenting the noticed changes in the best way. 
Micrographs were further enlarged photographically by 2.7 x. 
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2.4 Quantitative characterization of calcium distribution 
In some instances, minute changes in the calcium distribution and/or content of 
neurons, or axon terminals could not be determined by a plain visualization of the 
sections. In these cases quantitative characterization of the amount and distribution of 
electron dense deposits (EDDs), assumed to correspond to those of tissue calcium, 
was decided. Since simple grain counts would have consituted an imprecise measure 
of the amount of granules, because EDDs differ in shape and size, their volume 
fraction was determined in relation to appropriately selected reference (cytoplasmic-, 
axoplasmic-, or mitochondrial-) volumes. Volume fractions (volume-to-volume 
ratios) were determined on systematic-randomly made electron microscopic prints, 
using point counting procedures [Mayhew, 1992]. To determine mitochondrial 
calcium volume fractions, mitochondrial profiles were first marked then a sampling 
grid was superimposed on the micrographs. Grid points lying over EDDs (Pca) and the 
mitochondrial volume (Pmit) were counted, then pooled to each animal/muscle, or 
neuron type. (EPca, £Pmu). The EPca/2Pmu ratio was introduced to characterize the 
mitochondrial calcium content of the particular presynaptic terminal and 
motoneuron/animal. Similar calculations were applied to characterize non-
mitochondrial (axoplasmic- and cytoplasmic-) calcium volume fractions at the 
neuromuscular synapses and perikaryonal regions. 
2.5 Analytical microscopy 
Since the conclusions with regard to the calcium distribution of the tissue, made 
on the basis of point counting procedures, depended on the specificity of the 
histochemical reaction, the calcium content of the EDDs was time-to-time controlled, 
using the electron spectroscopic imaging (ESI) mode of the microscope [Bauer, 
1988]. For ESI, 20-30 nm thin unstained sections were prepapred, the significant 
calcium distribution was determined in randomly selected regions of the sections, then 
correlated with the distribution of the EDDs. To perform the ESI analysis individual 
images were recorded at 20,000-30,OOOx primary magnification by 80 kV 
accelerating voltage of the microscope, using an objective aperture of 90 pm and a 
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spectrometer entrance aperture of 650 pm with a slit width of 8-10 eV. Element 
specific- and background image pairs were recorded at energy loss values of 355 eV 
and 310 eV, respectively. Between 500 and 600 video images were recorded and 
averaged for each energy loss value. Next, the net calcium distribution was 
determined by subtracting the background image from the „edge" image. The 
significant calcium distribution pattern was visualized by color-coding the difference 
image according to the „mean" + 2.5xs.d. —> „mean" + 6xs.d. rule. This way pixels 
identifying significant signal were colored and retained in the analytical image, while 
the non-significant signal was eliminated. To check the correlation of the true calcium 
distribution with the pattern of the EDDs, this color-coded image was superimposed 
onto the black-and-white fine-structural digital image of the same area, recorded at the 
carbon absorption edge (dE=250 eV) (Figure 2.). 
Fig. 2. Calcium distribution is exemplified in a: dilated cisterns of the endoplasmic 
reticulum with internal calcium precipitates, and b: partially swollen mitochondrion 
surrounded by scattered cytoplasmic calcium deposits. The true (colored) calcium 
signal can be adequately correlated with the EDDs. 
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3. Results 
3.1 Ultrastructure and calcium distribution of spinal motoneurons 
in excitotoxicity 
The specific aim of these experiments was to document if in vivo exposure of 
motoneurons to excitotoxins could result in their degeneration and, particularly, if 
destabilization of their calcium homeostasis could be induced similarly to other 
examined animal models of ALS. Thus, ultrastructural alterations of spinal 
motoneurons of rats were analyzed and corresponding changes in the intracellular 
calcium distribution were characterized in a 24 hours interval following subdural 
injection of DL-HCA. Qualitative description of the evolution of alterations in the 
morphology and calcium distribution of motoneurons was performed. At the earliest 
time point, immediately after DL-HCA injection (0 h survival time), neither structural 
changes, nor shifts from the normal calcium levels could be documented (Fig 3). 
Fig.3. (A) Electron micrograph of a motoneuron from the lumbar section of the spinal 
cord of a 21-day-old untreated rat illustrates the normal ultrastructure and physiologic 
calcium distribution. (B) At 0 h survival time neither morphological changes nor 
elevated calcium can be seen. Oxalate-pyroantimonate fixation, m: mitochondrion, er: 
endoplasmic reticulum, G: Golgi apparatus, arrowhead: calcium deposits; bar: 0.5 pm. 
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By 1 hour following DL-HCA injection generally no structural changes and, at 
most, an increase in the cytoplasmic calcium level could be seen (Fig 4A). Some 
initial signs of degeneration only occasionally could be noticed, such as dilatation of 
cisterns of the endoplasmic reticulum (ER) and Golgi complex paralleled with 
calcium accumulation (Fig 4B). 
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Fig.4. Electron micrographs of motoneurons from the lumbar segment of the spinal 
cord of a DL-HCA injected rat at 1 hour survival time. (A) Regularly, no structural 
alterations are present, and only an elevated level of cytoplasmic calcium can be seen. 
(B) Exceptionally, slight degeneration of the endoplasmic reticulum, accompanied by 
calcium accumulation, can be observed. The majority of mitochondria are 
uninfluenced with only restricted calcium accumulation, m: mitochondrion, G: Golgi 
apparatus, arrowhead: calcium deposits bar: 0.5 pm. 
Considerably larger heterogeneity of the reactions of motoneurons to the EAA 
application could be noticed at 3 h survival time. The changes, as illustrated in Fig 5, 
ranged from a brief increase of cytoplasmic calcium level to a substantial calcium 
accumulation by organelles, accompanied by serious degeneration of mitochondria, or 
the ER/Golgi system, or both. 
Six hours after EAA injection strong fragmentation and vacuolization of the 
ER and the Golgi apparatus could be seen (Fig 6A). Clusters of calcium precipitates 
were regularly present in the swollen cisternae of the organelles. At this stage 
mitochondria were usually shrunken, with no visible calcium deposits. By 24 h 
following DL-HCA injection motoneurons typically lost their structural integrity with 
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only few cytoplasmic organelles remaining recognizable (Fig 6B). Very low calcium 
level was regularly present. 
Fig. 5. Electron micrographs of spinal motoneurons from DL-HCA injected rats in 
different stages of degeneration. (A) Plain cytoplasmic calcium increase with no 
structural damage. (B) Slight degeneration of the ER with a moderate calcium 
accumulation. (C) Localized mitochondrial swelling with calcium accumulation. The 
neighboring organelles are devoid of calcium. (D) Advanced vacuolization of the 
Golgi complex and ER with calcium accumulation. Mitochondria are shrunken and 
deficient of calcium, m: mitochondrion, er: endoplasmic reticulum, G: Golgi 
apparatus, arrowhead: calcium deposits; bar: 0.5 pm. 
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Fig. 6. Motoneurons from the lumbar section of the spinal cord from DL-HCA 
injected rats. (A) At 6 h following injection advanced vacuolization of the Golgi 
complex and the endoplasmic reticulum could be observed, which was paralleled by 
calcium accumulation. The neighboring mitochondria were regularly shrunken with 
no visible calcium. (B) At 24 h survival time complete disintegration of the 
cytoplasmic structure could be seen which was accompanied by depletion of the 
calcium from the organelles. G: Golgi apparatus, arrowhead: calcium deposits; bar: 
0.5 pm. 
3.2 Similar alterations of the motoneuronal calcium induced in the autoimmune-
and oxidative stress models of ALS 
The availability of animal models of both the sporadic- and familial forms of 
ALS provides the opportunity of the direct comparison of the similarities of 
degeneration of motoneurons and the corresponding changes in their intracellular 
calcium. The particular aim of this study was to prove that such animal models, 
developed on different etiological backgrounds, could manifest the same pattern of 
the altered calcium distribution of motoneurons. If this aim is achieved, the results 
could provide additional support for the idea that impaired calcium homeostasis might 
be responsible for the uniform clinico-pathological picture of ALS. Furthermore, 
these models afford the possibility of a more detailed analysis of the alteration of 
motoneuron populations, differently affected in the course of the disease, which could 
provide more details about the mechanism of the motoneuronal lesion during ALS. 
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For these experiments, to approach the chronic conditions exist in the patients 
as well as in the transgenic animals (modelling familial ALS) a slight modification of 
the passive transfer paradigm was applied: newborn rats were used, and daily IgG 
injections were made. Neuromuscular synapses in the hindlimb interosseus muscle 
and in the external eye muscle (superior rectus) were qualitatively characterized, 
representing vulnerable and viable motor axon terminals, respectively. In the 
interosseus muscles, obtained from both models, increased calcium could be seen in 
the mitochondria and synaptic vesicles (Figure 7), which was in good aggreement 
with the findings obtained by analyzing muscle biopsies from ALS patients. 
Fig. 7. Calcium accumulation and degeneration of motor axon terminals in the 
interosseus muscle of SOD1 mutant mice (A) and rats injected with ALS IgG (B). 
Qualitatively, the type of generation (rupture of the mitochondrial structure) and the 
degree of calcium accumulation are comparable to each other, m: mitochondrion, jf: 
junctional folds, sv: sypatic vesicles; bar: 0.5 pm. 
In contrast to the motor axon terminals of the interosseus muscles, in the 
oculomotor nerve terminals no mitochondrial degeneration/calcium accumulation 
could be seen. However, vacuolar structures, called as endosomes, with characteristic 
size of 2-3 pm, could be often seen (Figure 8). The majority of intraterminal calcium 
- which increased compared to the corresponding controls, like in the interosseus 
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muscles - was mainly concentrated in these structures. Though in most of the sections 
endosomes appeared intracellularly, serial sectioning of the blocks containing the 
superior rectus muscles from both the SOD1 transgenic mice and ALS IgG injected 
rats revealed that they were in contact with the extracellular space (Figure 8C, 8D). 
Since these connections were usually present in a single section, we concluded that 
they were confined to a narrow area, representing a fine tunnel to the extracellular 
space. Since these structures developed only in the terminals of the resistant type of 
motoneurons, we hypothesized that they may represent a component of the cellular 
defense system against the high calcium load in these models. 
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Fig. 8. Oculomotor nerve terminals from SOD1 mutant mice (A, B) and from rats 
injected with ALS IgG (B, D). Regularly, large vacuolar structures could be seen 
intracellularly, which concentrated the majority of intracellular calcium ( * ) , however, 
their connection with the extracellular space could be proved by serial sectioning (C, 
D). m: mitochondrion, jf: junctional folds, SM: striated muscle, sv: synaptic vesicles, 
arrowheads: connection of the endosomes to the extracellular space. Bar: 0.5 pm. 
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3.3 Ultrastructure and calcium distribution in spinal- and oculomotor neurons 
of SOD1 knock-out mice 
Similarities of the profiles of the altered calcium distribution of motoneurons 
in the models of sporadic- and familial ALS suggested, that impaired handling of the 
intracellular calcium level might be indeed responsible for their degeneration. Since 
the exact function of the mutant SOD1 enzyme was not known, it was desired to rule 
out the contribution of a deficient cytoplasmic antioxidant system to the observed 
collapse of the calcium homeostasis of the vulnerable motoneurons. The development 
of mice deficient of the SOD1 enzyme provided an ideal tool for this examination. 
A detailed characterization of the calcium distribution of a prototype of 
vulnerable (spinal) and resistant (oculomotor) neurons was performed at early (3 
months) and advanced adult age (11 months) of SOD 1 knock-out mice, and the results 
were compared to age-matched controls. Besides qualitative description, cytoplasmic 
and mitochondrial calcium levels were characterized quantitatively, too, by expressing 
the relative volume (volume fraction) of electron dense deposits. 
Fig. 9. Increased calcium could be demonstrated in spinal motoneurons of 11 months 
old wild-type mice (A). In SOD1 knock-out animals, even at this age, low level of 
intracellular calcium was present in the motoneurons of the spinal cord (B). m: 
mitochondrion, Go: Golgi apparatus, arrowhead: calcium deposit; bar: 0.5 pm. 
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In the wild-type animals no age-dependent changes were found in the 
intracellular calcium level of the oculomotor neurons. In contrast to neurons 
innervating external eye muscles, in spinal motoneurons, a marked increase of 
intracellular calcium could be noted as a function of age of control animals. No such 
age-dependent change in the calcium level could be observed either in spinal- or 
oculomotor neurons of the SOD1 knock-out mice. Consequently, qualitatively, 
differences only between the spinal motoneurons of wild-type and SOD1 knock-out 
animals clould be established, as the intracellular calcium level is considered (Figure 
9, 10). No degenerative changes could be seen at any time point of any cell type of 
either animals. (Figure 9, 10). 
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Fig.lO. In the oculomotor neurons of both wild-type (A) and SODl knock-out animals 
(B) low levels of intracellular calcium could be seen, even at the demonstrated age of 
11 months, m: mitochondrion, Go: Golgi apparatus, arrowhead: electron-dense 
deposit; bar: 0.5 pm. 
In our quantitative characterization of the calcium level of motoneurons we 
considered the mitochondrial and cytoplasmic changes separatedly. As summarized in 
Table 3, no significant changes could be demonstrated in the mitochondrial calcium 
content between the wild-type and control animals in any age-matched comparison. 
The calculations were extended to the corresponding motor axon terminals, too. 
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Tissue 
SOD1 knock-out Wild-type 
3 months 11 months 3 months 11 months 
Spinal cord 36.55 ±4.37 77.34 ±31.75 30.15 ±9.65 98.79 ±47.09 
Interosseus 
muscle 
18.80 ±9.81 52.75 ±20.82 18.94 ±6.57 64.40 ± 6.76 
Oculomotor 
nucleus 
38.42 ± 17.00 31.90 ±8.29 23.72 ±6.57 60.04 (n=l) 
External eye 
muscle 
13.63 ± 1.05 66.39 ±3.91 12.22 ± 5.60 23.15 ± 12.18 
Table 3. Calcium volume fraction (xlCT3) in mitochondria of motoneurons as a 
function of age of SOD1 knock-out and wild-type animals. Data are expressed as 
mean ± SEM. None of the differences between the corresponding age-matched 
controls and SOD1 knock-out groups were statistically significant. 
The non-mitochondrial calcium volume fractions were determined using a 
reference space of the corresponding perikaryonal, or axoplasmic volume, excluding 
mitochondrial profiles. Thus, these data contained contributions from the cytoplasm, 
endoplasmic reticulum, Golgi apparatus, and synaptic vesicles, as well. The calcium 
volume fraction numbers were usually smaller in the motor axon terminals than in the 
cell bodies, and exhibited an increase with age in the wild type animals (Figure 11 A, 
11C). With these data, as a physiological baseline, the correspondig numbers of the 
spinal motoneurons from the SOD1 knock-out animals were always smaller. This 
difference increased with age, and by the age of 11 months reached a significant level 
both in the perikaya and axon terminals of spinal motoneurons (Figure 11 A, 11C) but 
not in any region of the oculomotor neurons (Figure 1 IB, 11D). The age-dependent 
increase of non-mitochondrial calcium was always smaller, or negligible in the 
oculomotor system, compared to the spinal motoneurons of wild-type animals (Figure 
11A-D). 
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Fig. 11. Non-mitochondrial calcium volume fractions (% of the volume of calcium 
precipitates in relation to the cytoplasmic volume) in perikarya of spinal motoneurons 
(A), in motoneurons of the oculomotor nucleus (B), as well as in motor axon 
terminals of the interosseus muscle (C) and external eye muscles (D). Data are shown 
at 3 and 11 months of age of SOD1 knock-out mice (O) and wild-type animals ( • ) . 
The corresponding values were significantly different at 11 month of age of animals 




The aim of our study was to investigate the general validity of the calcium 
hypothesis in animal models of amyotrophic lateral sclerosis. On the basis of our 
previous experiments [Engelhardt et al, 1995; Siklos et al, 1998], as well as based on 
observations made in human biopsy material [Siklos et al, 1996], we assumed that -
regardless of the actual trigger of the lesion - the development of the uniform clinico-
pathological profile of the disease can be attributed to the impaired calcium 
homeostasis of motoneurons. To test this hypothesis we selected different animal 
models, based on different etiological backgrounds, and investigated if similar 
changes in the motoneuronal calcium distribution (or level) could be demonstrated. In 
these and related studies we also attempted to reveal individual steps, processes or 
cellular characteristics influencing the degree of injury' of calcium homeostasis in 
motoneuron populations. 
4.1 Excitotoxic lesion of motoneurons in vivo 
With regard to the excitotoxicty hypothesis, we did not want to investigate the 
justification of the concept, which, despite of firm supporting data, could be still 
debated. Particularly, it has been shown that Ca2+-permeable AMPA receptors are 
equally expressed in resistant- and vulnerable brain stem nuclei [Laslo et al, 2001], or 
alternatively, the Ca2+-non-permeable variant of the receptor is strongly expressed in 
vulnerable hypoglossal neurons [Paarmann et al, 2000]. Furthermore, splice variants 
of mRNA of the glial glutamate transporter, responsible for the reduced amount of 
EAAT2, are equally expressed in ALS patients and in normal individuals [Meyer et 
al, 1999], or, can be demonstrated in Alzheimer's disease-, and Lewy body dementia 
patients, as well [Honig et al, 2000]. Instead of planning additional (clarifying) 
experiments on the basis of the above arguments, assuming that excitotoxic lesion 
plays at least a partial role in the pathomechanism of ALS, we intended to 
demonstrate that impairment of motoneuronal calcium homeostasis and degeneration 
of motoneurons could be evoked by pure excitotoxic stress. 
In our excitotoxicity experiments DL-HCA, which is a nonspecific agonist of 
NMD A- and non-NMDA glutamate receptors, was directly applied to the spinal cord 
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of rats. As the main finding, we could document that acute EAA application could 
indeed induce calcium increase and degeneration in spinal motoneurons. The pattern 
of intracellular calcium increase exhibited a characteristic sequence in the observed 
period: a plain cytoplasmic increase was noted first, which was followed by 
sequestration of calcium by organelles, with predominant calcium accumulation either 
in the endoplasmic reticulum, or in mitochondria, or both. Finally, the calcium content 
was diminished in the disintegrating, degenerating cells. The documented intracellular 
calcium increase, followed by redistribution, always preceded the degeneration of the 
cell and its organelles, which suggests, that actually a calcium-induced/mediated 
destruction of the motoneurons could be evoked in the model. 
Ca2+ 
9+ 
Fig. 12. Some elements of the Ca -dependent cell destruction mechanism. Certain 
enzymatic processes (endonucleases, proteases), through their calcium-dependent 
activity, are able to exert direct injury, while others (e.g. phospholipases) induce the 
production of toxic intermediates. If calcium influx exceeds the efflux capacity (not 
shown) the intracellular buffers (CaBP, calcium-binding proteins; ER, endoplasmic 
reticulum; mitochondria) would be overwhelmed, which finally results in 
mitochondrial dysfunction, energy depletion, and apoptotic, or necrotic cell death, 
depending on the actually available energy. 
31 
The calcium-mediated cytotoxicity, particularly excitotoxicity is a well know 
phenomenon since decades [Olney, 1969]. Despite of intensive investigations in this 
field, however, the precise mechanism of the Ca2+-dependendent cell death is still 
poorly understood [for a recent review see e.g. Sattler & Tymianski, 2000]. Although 
numerous calcium-dependent enzymatic processes are known to participate in cellular 
destruction (illustrated in Figure 12.), it seems that not the calcium load itself, but the 
route of entry and the way of intracellular handling are the decisive factors in the final 
outcome of the initial injury [Sattler & Tymianski, 2000]. 
Although the exact sequence of molecular events cannot be reconstructed on the 
basis of our data obtained by electron microscopy, mainly due to the low time-
resolution of the technique, the results are in good agreement with the current concept 
of handling of intracellular calcium by calcium sequestering organelles. As the 
appropriate EAA receptors are activated, calcium influx and release from the internal 
stores (due to the activation of the IP3 receptors of the ER) could lead to an increase of 
intracellular calcium (Fig 4A) [Siesjo et al, 1999]. Next, a mitochondrial calcium 
uptake takes place, even at physiologic conditions [Werth & Thayer, 1994], 
preferably at those microdomains, where the ER and mitochondria are at intimate 
proximity (Fig 4B). If the calium load is high enough, however, a biphasic 
mitochondrial calcium uptake can be induced [Ichas & Mazat, 1998], before the final 
collapse of the mitochondrial homeostasis occurs. In the first phase this uptake is not 
paralleled by detectable mitochondrial swelling, which might correspond to those 
mitochondria in our material where only local calcium accumulation could be seen 
(Fig 4B). The second phase, accompanied by gradual swelling of organelles (Fig 5) 
could evetually lead to opening of mitochondrial permeability transition pore in its 
high conductance state, release of matrix calcium and disintegration of the organelles. 
Although parallel to these mitochondrial events an ATP-dependent reload of the ER-
stores could take place, explaining the heterogeneity of the observed calcium 
distribution at appr. 3 h survival time (Fig 5), the collapse of mitochondrial ATP 
synthesis should induce a secondary depletion of such stores, too. Finally, the 
mitochondrial permeability transition leads to the release of apoptosis inducing factors 
which results in apoptotic or necrotic cell death, depending on the available energy 
(ATP) of the actual cell [Kroemer et al, 1998; Nicotera & Lipton, 1999]. In accord 
with our results, similar sequence of calcium redistribution could be documented in in 
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vitro experiments, regardless if apoptotic or necrotic type of cell death was induced 
[Kruman & Mattson, 1999]. 
4.2 Correlation of disturbed calcium homeostasis of vulnerable and resistant 
motor axon terminals in models of familial- and sporadic ALS 
The availability of SOD1 mutant transgenic animals and the modified passive 
transfer model, based on regular IgG inoculation, made possible the extension of the 
above investigations not only to additional models, but also to study the consequences 
of chronic stress conditions, imitating better the true pathomechanisms of the human 
disease. In this comparative analysis of disturbed calcium homeostasis - in ALS 
models with entirely different etiologic backgrounds - it was also possible to correlate 
the changes in distinct motoneuron populations differently affected in the disease. 
Because we aimed to reveal differences in their calcium handling properties, for this 
comparison of calcium distribution, we choosed spinal motoneurons and oculomotor 
neurons, since their calcium buffer composition was already proved to be different 
[Alexianu et al, 1994; Siklós et al,-1998]. In light of the autoimmune theory and 
earlier data from passive transfer experiments [Engelhardt et al, 1995] we expected 
\ 
the major changes at the neuromuscular junctions, .thus, we focused our study to the 
corresponding motor axon terminals in the interosseus- and external eye muscles. 
The analysis of motor axon terminals of the interosseus muscle of both animal 
models revealed mitochondrial degeneration and and extensive calcium accumulation 
mainly in the mitochondria (Figure 7). These results were in agreement with previous 
findings obtained by examination of the same muscle after acute IgG treatment of 
animals [Engelhardt et al, 1995], or by analysis of muscle biopsy samples of sporadic 
ALS patients [Siklós et al, 1996]. 
The microscopic examination of the neuromuscular junctions in the external eye 
muscles also revealed similar alterations in the two models (Figure 8A, 8B), i.e. 
appearance of large vacuolar structures (endosomes) accumulating the majority of 
intraterminal calcium. The development of such structures was not unexpected on the 
basis of detailed analysis of motor nerve terminals of the superior rectus muscle of 
SOD1 transgenic mice [Siklós et al, 1998]. However, the present results proved that 
similar alterations of the calcium homeostasis could be equally induced in the models 
of the sporadic- and familial ALS. A further result of the present study is the^ 
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demonstration that the endosomes are in fact in contact with the extracellular space 
via a narrow, tunnel-like channel (Figure 8C, 8D). These findings may suggest a 
mechanism how could the oculomotor neurons resist the applied stress conditions, 
likely by specialized management of intracellular calcium, or through stabilization of 
their calcium homeostasis. 
The exact origin or identity of endosomes could not be determined on the basis of 
the present experiments, however, their development was probably connected to the 
peculiar modification of synaptic transmission in the oculomotor synapses. 
Stimulation of nerve terminals has been reported to lead to a transient increase of 
endosome-like organelles, because of the different kinetics of exo- and endocytosis 
[Takei et al, 1996], These vacuoles could posess very narow channels communicating 
with the extracellular space [Gad et al, 1998], similar to the endosomes documented in 
our study. Since increased intracellular calcium has been demonstrated to hinder 
vesicle membrane retrieval in a graded fashion [von Gersdorff & Matthews, 1994; 
Brodin et al, 1997], differential formation of endosomes in vulnerable and resistant 
motoneurons could result from different ways of handling of intracellular calcium 
possibly influenced by calcium binding protein content. Indeed, in a present study 
Burrone and colleagues [2002] demonstrated, that intracellular (endogenous) calcium 
buffers could decrease the release of vesicles towards the active zone, thus decrease 
the size of the rapidly releasable pool of vesicles. If we assume that, in such a way, a 
saturation of the reserve pool of vesicles could take place, this may favour a decreased 
rate of endocytosis and a formation of a non-pinched off membrane-enclosed 
structure, i.e. endosome (Figure 13). 
Fig. 13. Endogenous calcium buffers 
(CaBP) in axon terminals can 
decrease the release of vesicles 
towards the periphery of the active 
zone (1). Thus, probaly the saturation 
of the reserve pool of vesicles might 
develop, which, in turn, might 
decrease the rate of retrieval of 
vesicles (2), favouring the formation 
of endosomes. The endosome 
membrane, largely being constituted 
of vesicle membrane, possessing 
calcium pumps, would help to keep 
cytoplasmic calcium at low level. 
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As an alternative explanation for the development of endosomes we should keep in 
mind that endosome-like structures usually develop after prolonged stimulation 
[Leenders et al, 2002], offering an alternative vesicle recycling route, probably to 
compensate for the exhaustion of the releasable pool of vesicles. Since, if calcium 
binding proteins (i.e. endogenous calcium buffers) are present, the releasable pool is 
exhausted faster [Burrone et al, 2002], thus endosomes may develop preferentially at 
those axon terminals, where the cytoplasmic calcium buffering capacity is larger. In 
our proposed model, regardless of the actual driving force for their development, 
endosomes would specifically build up in axon terminals with larger cytosolic 
calcium binding capacity. Since the membrane of endosomes would be largely 
constituted from synaptic vesicle membrane, possessing ATP-dependent calcium 
pumps directed to the luminal domain [Michaelson et al, 1980], these structures 
would facilitate the removal of calcium from the intracellular space, compensating for 
the calcium load invoked by the presence of ALS IgG, or the mutant SOD1 enzyme. 
4.3 Cooperation of cytosolic free-radical- and calcium homeostasis in SOD1 
knock-out animals 
The availability of SOD 1 knock-out animals made possible the refined analysis 
of the role of the cytosolic antioxidant system in the pathomechanism of models of 
ALS. Since these animals - although were more prone to injury than the wild-type 
controls [Reaume at al, 1996] - developed normally, which suggests that they could 
compensate for the loss of a component of the antioxidant defense system. Since the 
synergetic effect of the neuronal free-radical- and calcium homeostasis was suggested 
[Mattson, 1998], we decided to study the differential changes of the calcium 
distribution in motoneuron populations with different calcium binding protein 
composition (i.e. spinal-, versus oculomotor neurons), known to be affected in the 
disease in a different way. During these studies we documented that (i) the 
mitochondrial calcium distribution was not affected in either of the neuron 
populations, and (ii) the cytoplasmic calcium distribution was different from age-
matched controls only in the spinal motor neurons. 
With regard to the mitochondrial calcium level in SOD1 knock-out animals, we 
should keep in mind that the main source of superoxide radicals (0"~), the target of 
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the S0D1 enzyme, is the mitochondria where SOD2 (Mn-SOD) is present, and 
functioning as the main defense system [Michiels et al, 1994], Thus, it is likely that 
under unchallenged (physiological) conditions no remarkable 0*~ stress is put on 
mitochondria. 
Concerning the cytoplasmic calcium, we noted a selective age-dependent increase 
of the calcium level of the spinal motoneurons in relation to the oculomotor neurons 
in wild-type animals, which supports that intrinsic cellular properties affect calcium 
levels during aging [Kirischuk & Verkhratsky, 1996; Verkhratsky & Toescu, 1998]. 
Knowing that, at least certain calcium binding proteins are present in oculomotor 
neurons, which are missing in the spinal motoneurons, this observation suggest that 
stabilization of calcium homeostasis during aging is associated with the presence of 
certain calcium binding proteins, which thus afford neuroprotection [Clementi et al, 
1996]. 
An unexpected finding of the present experiments was the relative decrease of 
cytoplasmic calcium from the spinal motoneurons of SOD1 knock-out animals 
compared to the age-matched controls. No such changes were noted either in the axon 
terminals or perikarya of the oculomotor neurons (Figure 11). These data suggest that 
decrements in the free-radical defense system could selectively impair calcium 
homeostasis in neurons with presumably lower calcium buffer capacity. Indeed, 
recent physiological and anatomical characterization of SOD1 knock-out mice 
revealed a slow development of mild, chronic peripheral hindlimb axonopathy and a 
moderate decline in motor unit number, suggesting impaired sprouting. [D. Flood & 
S. Shefner, personal communication]. This finding could be explained on the basis of 
the observed reduction of calcium in spinal motoneurons, since suitable intracellular 
calcium levels and intact intracellular stores are known to be necessary for synapse 
remodeling and neurite elongation [Kocsis et al, 1993; Mattson & Kater, 1987; 
Suares-Isla et al, 1984)]. 
Although brain tissue level of lipid peroxidation and protein carbonyl content 
demonstrated no oxidative damage in SOD1 knock-out mice compared to wild-type 
controls [Reaume et al, 1996], a mechanism could be proposed how the lack of SOD I 
enzyme could lead to minute changes in the calcium homeostasis. Changes could be 
primarily expected at the organellar store, the ER, due to its intimate geometrical 
proximity to mitochondria, the main source of O*". {The lack of SOD 1 activity in the 
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cytosol and the resultant primary breakdown route of O* radicals through the 
reaction 0*~ + NO* -» ONOO" [Warner, 1994], would imply that (1) the 0*~ 
level in the cytosol is slightly increased, (2) the cytosolic ONOO " concentration is 
proportionally increased, and (3) the cytosolic NO * concentration is decreased (since 
the competition for O*" would be now dominated by NO* alone)}, (i) Effects of 0*~ 
on intracellular calcium homeostasis were directly studied on isolated sarcoplasmic 
reticulum (SR) preparations, and 0*~ produced less calcium accumulation in SR due 
to increased calcium permeability [Okabe et al, 1988]. (ii) In calf pulmonary artery 
endothelial cells, ONOO " donors selectively decreased agonist-stimulated influx of 
external Ca2+, and depleted internal stores of releasable Ca2+ [Elliott, 1996], (iii) 
Finally, NO* has been documented to modulate Ca2" mobilization from internal stores 
in human platelets [Sang et al, 1996], and function as a sensor for [Ca2+]j [Suarez-Isla 
et al, 1984]. Thus, if decreasing concentrations of NO* have any effect, they should 
facilitate the release from the calcium stores and deplete such stores. The above 
processes, acting either individually, or together, could reduce the intracellular storage 
capacity of membrane enclosed organelles, making them functionally "leaky". 
Fig. 14. The effect of cytosolic 
calcium buffers on the intracellular 
calcium content, on the basis of Hofer 
et al [1998], With low cytosolic buffer 
capacity calcium ions leaking from 
the organelles, reach the Ca-ATPase 
pumps on the plasma membrane and 
will be extruded (1). With effective 
cytosolic buffering (CaBP), however, 
calcium ions leaving the ER would be 
captured (2) and recycled (2) by the 
SERCA pumps of the ER. 
The protection of oculomotor neurons from such a decrease of intracellular 
calcium could be explained on the basis of their higher calcium binding protein 
content, as proposed by Hofer at al [1998] (Figure 14). Accordingly, in oculomotor 
neurons, assuming the same effects of the O * ~ breakdown components, calcium ions 
released from the "leaky" internal stores can be immediately captured by calcium 
binding protein molecules and recycled into the stores. 
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4.4 A synthetic model of the calcium-mediated degeneration of motoneurons 
in amyotrophic lateral sclerosis 
On the basis of our experiments we propose that impaired management of 
intracellular calcium is the key factor in coupling different pathways leading to cell 
destruction in models of ALS, consequently, stabilization of motoneuronal calcium 
homeostasis could be a potential tool to increase their resistance in stress conditions. 
The summary of our present concept is illustrated in Figure 15, below. 
(proteases, phopholipases, endonucleases) and indirect destructive mechanisms 
(production of free radicals) are initiated. Normally, free radicals are neutralized by 
appropriate components of the cellular defense system, however, if a mutant enzyme 
is present (SOD1), the reaction is shifted towards the production of more harmful 
species. The highly reactive (and diffusibile) hydroxyl radicals may damage 
cytoskeletal components, as well as pumps/transport molecules (e.g. glutamate 
transporters) on the neighbouring cells. Impaired glutamate transport could induce 
overexcitation of appropriate receptors leading to further increase of intracellular 
calcium. The mechanism might be paralleled by calcium influx through voltage-gated 
calcium channels, due to IgG binding, and release of calcium from intracellular stores 
as a consequence of activation of metabotropic receptors. If the calcium increase 
endures, it might overwhelm extrusion pumps and intracellular-, particularly 
mitochondrial storing capacity, thus might impair mitochondrial function, leading to 
overproduction of free radicals, depletion of ATP, and, finally, the process culminates 
in the opening of the mitochondrial megachannel leading to cell death. 
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On the basis of the above scheme we anticipate that the stabilization of 
motoneuronal calcium homeostasis might improve their viability in different stress 
conditions. Indeed, in prior in vitro experiments transfection of motoneurons with 
calbindin D 2 s k prevented A L S IgG-mediated cytotoxicity [Ho et al, 1996] . A further 
support of the concept was obtained recently by developing transgenic mice 
overexpressing parvalbumin in their motoneurons [Beers et al, 2 0 0 1 ] . Introducing 
these animals into experimental paradigms modelling sporadic- and familial ALS, by 
inoculating ALS IgG, and crossing to SOD1 mutant mice, respectively, significant 
improvement in the viability of the (normally) vulnerable spinal motoneurons could 
be demonstrated [Beers et al, 2 0 0 1 ] . 
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